Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02365064 · ClinicalTrials.gov registry record · NA

CPAP vs ASV for Insomnia

A NA study, sponsored by ResMed.

Completed
Registry status
NA
Development phase
78
Enrollment target

NCT02365064 is a NA study that has completed, run by ResMed. The registered enrollment target is 78 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02365064, a NA study, has completed, sponsored by ResMed.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target

Study Summary

The study will determine which of two different types of positive airway pressure (PAP therapy) modes are more effective in reducing sleep breathing events in chronic insomnia patients and in decreasing insomnia severity.

Interventions

  • DEVICE AirCurve 10 ASV

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2015-02
Est. Completion 2017-12-01
Phase NA

Sponsor

ResMed

25 total trials

What the Registry Record Tells You About NCT02365064

The ClinicalTrials.gov registry entry for NCT02365064 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which AirCurve 10 ASV is the first listed.

NCT02365064 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02365064 about?

NCT02365064 is a clinical study titled "CPAP vs ASV for Insomnia". The study will determine which of two different types of positive airway pressure (PAP therapy) modes are more effective in reducing sleep breathing events in chronic insomnia patients and in decreasing insomnia severity.

What is the current status of trial NCT02365064?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2015-02. Estimated completion is 2017-12-01.

What interventions are being tested in trial NCT02365064?

The interventions under investigation include: AirCurve 10 ASV (DEVICE).

Who is sponsoring clinical trial NCT02365064?

This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.